100 related articles for article (PubMed ID: 8602983)
1. Lack of DNA synthesis among CD34+ cells in cord blood and in cytokine-mobilized blood.
Leitner A; Strobl H; Fischmeister G; Kurz M; Romanakis K; Haas OA; Printz D; Buchinger P; Bauer S; Gadner H; Fritsch G
Br J Haematol; 1996 Feb; 92(2):255-62. PubMed ID: 8602983
[TBL] [Abstract][Full Text] [Related]
2. Comparison of CD34+ subsets and clonogenicity in human bone marrow, granulocyte colony-stimulating factor-mobilized peripheral blood, and cord blood.
Cho SH; Chung IJ; Lee JJ; Park ML; Kim HJ
J Korean Med Sci; 1999 Oct; 14(5):520-5. PubMed ID: 10576147
[TBL] [Abstract][Full Text] [Related]
3. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or not mobilized with granulocyte colony-stimulating factor and/or stem cell factor.
Donahue RE; Kirby MR; Metzger ME; Agricola BA; Sellers SE; Cullis HM
Blood; 1996 Feb; 87(4):1644-53. PubMed ID: 8608259
[TBL] [Abstract][Full Text] [Related]
5. Transduction of retrovirus-mediated NeoR gene into CD34+ cells purified from granulocyte colony-stimulating factor (G-CSF)-mobilized infant and cord blood.
Abe T; Ito M; Okamoto Y; Kim HJ; Takaue Y; Yasutomo K; Makimoto A; Yamaue T; Kawano Y; Watanabe T; Shimada T; Kuroda Y
Exp Hematol; 1997 Aug; 25(9):966-71. PubMed ID: 9257810
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
Steen R; Tjønnfjord GE; Egeland T
J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
[TBL] [Abstract][Full Text] [Related]
7. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T
Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
[TBL] [Abstract][Full Text] [Related]
8. Biological characterization of CD34+ cells mobilized into peripheral blood.
Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic analysis and characterization of CD34+ cells from normal human bone marrow, cord blood, peripheral blood, and mobilized peripheral blood from patients undergoing autologous stem cell transplantation.
Bender JG; Unverzagt K; Walker DE; Lee W; Smith S; Williams S; Van Epps DE
Clin Immunol Immunopathol; 1994 Jan; 70(1):10-8. PubMed ID: 7505211
[TBL] [Abstract][Full Text] [Related]
10. Use of flow cytometric CD34 analysis to quantify hematopoietic progenitor cells.
Fritsch G; Buchinger P; Printz D
Leuk Lymphoma; 1993 Aug; 10(6):443-51. PubMed ID: 7691307
[TBL] [Abstract][Full Text] [Related]
11. Harvesting, characterization, and culture of CD34+ cells from human bone marrow, peripheral blood, and cord blood.
Van Epps DE; Bender J; Lee W; Schilling M; Smith A; Smith S; Unverzagt K; Law P; Burgess J
Blood Cells; 1994; 20(2-3):411-23. PubMed ID: 7538347
[TBL] [Abstract][Full Text] [Related]
12. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy.
Fruehauf S; Veldwijk MR; Krämer A; Haas R; Zeller WJ
Stem Cells; 1998; 16(4):271-9. PubMed ID: 9708449
[TBL] [Abstract][Full Text] [Related]
13. Quantitative cell-cycle progression analysis of the first three successive cell cycles of granulocyte colony-stimulating factor and/or granulocyte-macrophage colony-stimulating factor-stimulated human CD34+ bone marrow cells in relation to their colony formation.
Lardon F; Van Bockstaele DR; Snoeck HW; Peetermans ME
Blood; 1993 Jun; 81(12):3211-6. PubMed ID: 7685198
[TBL] [Abstract][Full Text] [Related]
14. The in vitro effects of stem cell factor and PIXY321 on myeloid progenitor formation (CFU-GM) from immunomagnetic separated CD34+ cord blood.
Cairo MS; Law P; van de Ven C; Plunkett JM; Williams D; Ishizawa L; Gee A
Pediatr Res; 1992 Sep; 32(3):277-81. PubMed ID: 1383918
[TBL] [Abstract][Full Text] [Related]
15. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow.
van de Ven C; Ishizawa L; Law P; Cairo MS
Exp Hematol; 1995 Nov; 23(12):1289-95. PubMed ID: 7589284
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle.
Lucotti C; Malabarba L; Rosti V; Bergamaschi G; Danova M; Invernizzi R; Pecci A; Ramajoli I; Perotti C; Torretta L; De Amici M; Salvaneschi L; Cazzola M
Br J Haematol; 2000 Mar; 108(3):621-8. PubMed ID: 10759722
[TBL] [Abstract][Full Text] [Related]
18. Rapid discrimination of early CD34+ myeloid progenitors using CD45-RA analysis.
Fritsch G; Buchinger P; Printz D; Fink FM; Mann G; Peters C; Wagner T; Adler A; Gadner H
Blood; 1993 May; 81(9):2301-9. PubMed ID: 7683216
[TBL] [Abstract][Full Text] [Related]
19. Quantitative expression of adhesion molecules on granulocyte colony-stimulating factor-mobilized peripheral blood, bone marrow, and cord blood CD34+ cells.
Gigant C; Latger-Cannard V; Bensoussan D; Feugier P; Bordigoni P; Stoltz JF
J Hematother Stem Cell Res; 2001 Dec; 10(6):807-14. PubMed ID: 11798507
[TBL] [Abstract][Full Text] [Related]
20. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]